USPTO serial 79032884
NANOCYTES
Reviewed by CopyMark Law Group
Reg. 3572714Status 404
- Filing date
- Status date
- Registration date
- Feb 10, 2009
- Examiner
- BLANE, SUZANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NANOCYTES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
DE
Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
DE
Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Fraunhofer-Gesellschaft zur Förderung; der angewandten Forschung e.V.
80636 München, DE
Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung; der angewandten Forschung e.V.
Fraunhofer-Gesellschaft zur Förderung; der angewandten Forschung e.V.
80636 München, DE
Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung; der angewandten Forschung e.V.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. SCOTT ALPRIN
M. Scott Alprin Alprin Law Offices5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Hybrid biological and synthetic reagents and assays based on particles produced biologically, chemically or by gene technology, except biological cells and viruses, for commercial and scientific purposes, namely, for biological and immunological research, in diagnostic and medical technology; biological and chemical preparations, namely, reagents and assays based on particles, except biological cells and viruses, used for pharmaceutical and science industries, namely, biological and immunological research, in diagnostic and medical technology | SECTION 71 - CANCELLED | — |
| 005 | Biological and chemical preparations, except biological cells and viruses as well as preparations containing them, for medical purposes, namely, for the diagnosis and treatment of viral, infectious and bacterial diseases and diseases of the gastrointestinal tract, the cardiovascular system, the central nervous system, musculo-skeletal system, the eye, nose and oropharynx, the respiratory system, endocrine problems, the reproductive and urinary system, contraception, obstetrics and gynecology, the skin, immunology system, allergic disorders, nutrition, neoplastic disorders and diagnostics, as well as for veterinary purposes, namely in the field of anesthesiology, behavior, dermatology, emergency and critical care, internal medicine, cardiology, oncology, neurology, radiology and surgery; coated particles, namely, hybrid biological and synthetic reagents and assays based on particles produced biologically, chemically or by gene technology, except biological cells and viruses, for diagnostic analyses and for therapy, in particular in the area of oncology; biological and chemical preparations, except biological cells and viruses as well as products and preparations containing them, for medical purposes, namely, for the diagnosis and treatment of viral, infectious and bacterial diseases and diseases of the gastrointestinal tract, the cardiovascular system, the central nervous system, musculo-skeletal system, the eye, nose and oropharynx, the respiratory system, endocrine problems, the reproductive and urinary system, contraception, obstetrics and gynecology, the skin, immunology system, allergic disorders, nutrition, neoplastic disorders and diagnostics, as well as veterinary purposes, namely, in the field of anesthesiology, behavior, dermatology, emergency and critical care, internal medicine, cardiology, oncology, neurology, radiology and surgery; diagnostic reagents for in-vitro and in-vivo use in biochemistry, clinical chemistry and microbiology | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
- Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
- Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung; der angewandten Forschung e.V.
- Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung; der angewandten Forschung e.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named NANOCYTES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 24, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 11, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 11, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 16, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 20, 2016 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 20, 2016 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 11, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 11, 2015 | C71T | CANCELLED SECTION 71 | — |
| Jan 11, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 1, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 15, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 15, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 10, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 10, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 7, 2009 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jan 7, 2009 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jan 7, 2009 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| May 30, 2008 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 9, 2008 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 8, 2008 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| May 8, 2008 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Mar 7, 2008 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 30, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 8, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 3, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 3, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 27, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 12, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2007 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 14, 2007 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 14, 2007 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 14, 2007 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 14, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 14, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 19, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 19, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 8, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 19, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 19, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 17, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 16, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Jan 4, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |